If you need more lookups,
subscriptions start at $34 USD/month.
Keith Phillips Location
United Kingdom
Keith Phillips Work
Vice President, Head of Novel Therapeutic Modalities @ (April 2023 - Present)
Associate Vice President, Neuroscience Next Generation Therapeutics @ Eli Lilly and Company (January 2020 - April 2023)
Research Advisor @ Eli Lilly and Company (October 2019 - January 2020)
Principal Research Scientist @ Eli Lilly and Company (October 2017 - January 2020)
Senior Research Scientist @ Eli Lilly and Company (November 2014 - October 2017)
Research Scientist @ Eli Lilly and Company (May 2011 - October 2014)
Postdoctoral Research Fellow @ (January 2008 - May 2011)
Student Placement @ Eli Lilly (August 2002 - August 2003)
Keith Phillips Education
Cardiff University / Prifysgol Caerdydd
PhD (Neuroscience)
2003-2007
University of Southampton
BSc (Pharmacology)
1999-2004
Keith Phillips Skills
Biomarkers
In Vivo
Electrophysiology
Ion Channels
Neuropharmacology
Target Identification
Animal Models
Neuroscience
Translational Medicine
Drug Discovery
Pharmacology
In Vitro
Public Speaking
Project Management
Teaching
PowerPoint
Customer Service
Molecular Biology
Keith Phillips Summary
Keith Phillips, based in United Kingdom, is currently a Vice President, Head of Novel Therapeutic Modalities at Grünenthal Group. Keith Phillips brings experience from previous roles at Eli Lilly and Company. Keith Phillips holds a 2003 - 2007 PhD in Neuroscience @ Cardiff University / Prifysgol Caerdydd. With a robust skill set that includes Biomarkers, In Vivo, Electrophysiology, Ion Channels, Neuropharmacology and more. Keith Phillips has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Keith Phillips?
Find contact details for 700 million professionals.